Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition

[1]  T. Rème,et al.  Transcriptome of retrovirally transduced CD8+ lymphocytes: influence of cell activation, transgene integration, and selection process. , 2008, Molecular immunology.

[2]  T. Schumacher,et al.  T-Cell Receptor Gene Therapy of Established Tumors in a Murine Melanoma Model , 2008, Journal of immunotherapy.

[3]  H. Heslop,et al.  Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes. , 2007, Blood.

[4]  D. Hart,et al.  T-cell receptor gene therapy for cancer: the progress to date and future objectives , 2007, Expert opinion on biological therapy.

[5]  A. Schambach,et al.  Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  S. Rosenberg,et al.  Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond. , 2007, Cancer research.

[7]  M. Sadelain,et al.  The genetic engineering of hematopoietic stem cells: the rise of lentiviral vectors, the conundrum of the ltr, and the promise of lineage-restricted vectors. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  Donald B Kohn,et al.  Lentiviral vectors ready for prime-time , 2007, Nature Biotechnology.

[9]  John R. Mascola,et al.  Gene transfer in humans using a conditionally replicating lentiviral vector , 2006, Proceedings of the National Academy of Sciences.

[10]  S. Rosenberg,et al.  Gene Transfer of Tumor-Reactive TCR Confers Both High Avidity and Tumor Reactivity to Nonreactive Peripheral Blood Mononuclear Cells and Tumor-Infiltrating Lymphocytes1 , 2006, The Journal of Immunology.

[11]  S. Rosenberg,et al.  Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes , 2006, Science.

[12]  Yangbing Zhao,et al.  Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability. , 2006, Cancer research.

[13]  T. Rubino,et al.  Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes. , 2006, Journal of virological methods.

[14]  V. Baekelandt,et al.  Comparison of lentiviral vector titration methods , 2006, BMC biotechnology.

[15]  Jeff Holst,et al.  Generation of T-cell receptor retrogenic mice , 2006, Nature Protocols.

[16]  Clelia Di Serio,et al.  Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration , 2006, Nature Biotechnology.

[17]  J. Holst,et al.  Rapid analysis of T-cell selection in vivo using T cell–receptor retrogenic mice , 2006 .

[18]  A. Kolokoltsov,et al.  Use of recombinant lentivirus pseudotyped with vesicular stomatitis virus glycoprotein G for efficient generation of human anti-cancer chimeric T cells by transduction of human peripheral blood lymphocytes in vitro , 2006, Virology Journal.

[19]  G. Margison,et al.  Multicistronic lentiviral vectors containing the FMDV 2A cleavage factor demonstrate robust expression of encoded genes at limiting MOI , 2006, Virology Journal.

[20]  S. Rosenberg,et al.  Recognition of Fresh Human Tumor by Human Peripheral Blood Lymphocytes Transduced with a Bicistronic Retroviral Vector Encoding a Murine Anti-p53 TCR , 2005, The Journal of Immunology.

[21]  J. Ellis.  Silencing and variegation of gammaretrovirus and lentivirus vectors. , 2005, Human gene therapy.

[22]  S. Rosenberg,et al.  Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. , 2005, The Journal of clinical investigation.

[23]  S. Rosenberg,et al.  Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions. , 2005, Human gene therapy.

[24]  Andrea L. Szymczak,et al.  Development of 2A peptide-based strategies in the design of multicistronic vectors , 2005, Expert opinion on biological therapy.

[25]  K. Jooss,et al.  Stable antibody expression at therapeutic levels using the 2A peptide , 2005, Nature Biotechnology.

[26]  Richard A. Morgan,et al.  Primary Human Lymphocytes Transduced with NY-ESO-1 Antigen-Specific TCR Genes Recognize and Kill Diverse Human Tumor Cell Lines , 2005, The Journal of Immunology.

[27]  Mark M Davis,et al.  How T cells 'see' antigen , 2005, Nature Immunology.

[28]  L. Naldini,et al.  Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters , 2005, Nature Biotechnology.

[29]  M. Wiznerowicz,et al.  Harnessing HIV for therapy, basic research and biotechnology. , 2005, Trends in biotechnology.

[30]  I. Plavec,et al.  Enhanced transgene expression in quiescent and activated human CD8+ T cells. , 2004, Human gene therapy.

[31]  M. Ryan,et al.  Targeting of Proteins Derived from Self‐Processing Polyproteins Containing Multiple Signal Sequences , 2004, Traffic.

[32]  E. Robinet,et al.  Retrovirus-mediated gene transfer in human primary T lymphocytes induces an activation- and transduction/selection-dependent TCR-B variable chain repertoire skewing of gene-modified cells. , 2004, Stem cells and development.

[33]  Smaroula Dilioglou,et al.  Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide–based retroviral vector , 2004, Nature Biotechnology.

[34]  R. Siezen,et al.  Furin is a subtilisin-like proprotein processing enzyme in higher eukaryotes , 1990, Molecular Biology Reports.

[35]  W. Kao,et al.  Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  S. Rosenberg,et al.  High Efficiency TCR Gene Transfer into Primary Human Lymphocytes Affords Avid Recognition of Melanoma Tumor Antigen Glycoprotein 100 and Does Not Alter the Recognition of Autologous Melanoma Antigens , 2003, The Journal of Immunology.

[37]  S. Rosenberg,et al.  Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells , 2003, The Journal of experimental medicine.

[38]  L. Naldini,et al.  Human T lymphocytes transduced by lentiviral vectors in the absence of TCR activation maintain an intact immune competence. , 2003, Blood.

[39]  X. Zhan,et al.  Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[40]  J. Thomson,et al.  High‐Level Sustained Transgene Expression in Human Embryonic Stem Cells Using Lentiviral Vectors , 2003, Stem cells.

[41]  Michel Sadelain,et al.  Targeting tumours with genetically enhanced T lymphocytes , 2003, Nature Reviews Cancer.

[42]  E. Robinet,et al.  Influence of ex vivo expansion and retrovirus-mediated gene transfer on primary T lymphocyte phenotype and functions. , 2002, Journal of hematotherapy & stem cell research.

[43]  N. Saitou,et al.  Adaptive evolution of the IgA hinge region in primates. , 2002, Molecular biology and evolution.

[44]  T. Schumacher,et al.  T-cell-receptor gene therapy , 2002, Nature Reviews Immunology.

[45]  I. Verma,et al.  Transgenesis by lentiviral vectors: Lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[46]  J. Melo,et al.  Retrovirus-mediated gene transfer in primary T lymphocytes impairs their anti-Epstein-Barr virus potential through both culture-dependent and selection process-dependent mechanisms. , 2002, Blood.

[47]  David Baltimore,et al.  Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors , 2002, Science.

[48]  N. Taylor,et al.  Lentivirus-mediated gene transfer in primary T cells is enhanced by a central DNA flap , 2001, Gene Therapy.

[49]  D. Krysan,et al.  Quantitative Characterization of Furin Specificity , 1999, The Journal of Biological Chemistry.

[50]  Luigi Naldini,et al.  Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo , 1997, Nature Biotechnology.

[51]  F. Gage,et al.  In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.

[52]  O. Elroy-Stein,et al.  Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy. , 1992, Nucleic acids research.

[53]  M. Ryan,et al.  Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. , 1991, The Journal of general virology.

[54]  S. Rosenberg,et al.  Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. , 1989, Journal of immunology.

[55]  R. Jaenisch,et al.  Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cells , 1986, Cell.

[56]  S. Goff,et al.  Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA , 1986, Journal of virology.